D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EPZM holding history
Epizyme, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EPZM overviewAll 13F holders of EPZMFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −1,728,102−100.0% | Sold out | Holders |
| Q2 2022 | 1,728,102 | $2.54M | <0.1% | −592,596−25.5% | Reduced | Holders |
| Q1 2022 | 2,320,698 | $2.67M | <0.1% | +2,061,176+794.2% | Added | Holders |
| Q4 2021 | 259,522 | $649.0K | <0.1% | +259,522 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −44,130−100.0% | Sold out | Holders |
| Q1 2021 | 44,130 | $384.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.